Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer

References

• Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289. doi:10.1146/annurev-cellbio-101512-12232625288114
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology. 2015;4(9):e1027472. doi:10.1080/2162402X.2015.102747226405598
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol. 2011;33(5):441–454. doi:10.1007/s00281-010-0234-821688197
   PubMed Web of Science ®Google Scholar
• Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007;67(7):2912–2915. doi:10.1158/0008-5472.CAN-07-052017409393
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Tumor-derived exosomes and their role in tumor-induced immune suppression. Vaccines (Basel). 2016;4(4):35. doi:10.3390/vaccines4040035
   Web of Science ®Google Scholar
• Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol. 2011;2011:842849. doi:10.1155/2011/84284922190973
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Tumor-derived exosomes and their role in cancer progression. Adv Clin Chem. 2016;74:103–141. doi:10.1016/bs.acc.2015.12.00527117662
   PubMed Web of Science ®Google Scholar
• Xiang X, Poliakov A, Liu C, et al. Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer. 2009;124(11):2621–2633. doi:10.1002/ijc.2424919235923
   PubMed Web of Science ®Google Scholar
• Khaled YS, Ammori BJ, Elkord E. Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J Immunol Res. 2014;2014:879897. doi:10.1155/2014/87989724741628
   PubMed Web of Science ®Google Scholar
• Wang J, De Veirman K, De Beule N, et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget. 2015;6(41):43992–44004. doi:10.18632/oncotarget.608326556857
   PubMedGoogle Scholar
• Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013;13(10):739–752. doi:10.1038/nrc358124060865
   PubMed Web of Science ®Google Scholar
• Motallebnezhad M, Jadidi-Niaragh F, Qamsari ES, Bagheri S, Gharibi T, Yousefi M. The immunobiology of myeloid-derived suppressor cells in cancer. Tumour Biol. 2016;37(2):1387–1406. doi:10.1007/s13277-015-4477-926611648
   PubMedGoogle Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162–174. doi:10.1038/nri250619197294
   PubMed Web of Science ®Google Scholar
• Khaled YS, Ammori BJ, Elkord E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol. 2013;91(8):493–502. doi:10.1038/icb.2013.2923797066
   PubMed Web of Science ®Google Scholar
• Toh B, Wang X, Keeble J, et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 2011;9(9):e1001162. doi:10.1371/journal.pbio.100116221980263
   PubMed Web of Science ®Google Scholar
• Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 2004;6(4):409–421. doi:10.1016/j.ccr.2004.08.03115488763
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10(2):111–122. doi:10.1038/nri270820098459
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang Y, Kuzel TM, Zhang B. Regulating tumor Myeloid-derived suppressor cells by MicroRNAs. Cancer Cell Microenviron. 2015;2(1):e637. doi:10.14800/ccm.637
   Google Scholar
• El Gazzar M. microRNAs as potential regulators of myeloid-derived suppressor cell expansion. Innate Immun. 2014;20(3):227–238. doi:10.1177/175342591348985023757323
   PubMed Web of Science ®Google Scholar
• Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep. 2012;27(6):1759–1764. doi:10.3892/or.2012.170922407237
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Shi Y, et al. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med. 2011;15(9):1887–1895. doi:10.1111/j.1582-4934.2010.01194.x21029372
   PubMed Web of Science ®Google Scholar
• Zheng Q, Chen C, Guan H, Kang W, Yu C. Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis. Oncotarget. 2017;8(28):46611–46623. doi:10.18632/oncotarget.1667928402940
   PubMedGoogle Scholar
• Price C, Chen J. MicroRNAs in cancer biology and therapy: current status and perspectives. Genes Dis. 2014;1(1):53–63. doi:10.1016/j.gendis.2014.06.00425473652
   PubMedGoogle Scholar
• Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787–798.14697198
   PubMed Web of Science ®Google Scholar
• Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495–500. doi:10.1038/ng153615806104
   PubMed Web of Science ®Google Scholar
• John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2(11):e363. doi:10.1371/journal.pbio.002036315502875
   PubMed Web of Science ®Google Scholar
• Neviani P, Fabbri M. Exosomic microRNAs in the tumor microenvironment. Front Med (Lausanne). 2015;2:47. doi:10.3389/fmed.2015.0004726258125
   PubMedGoogle Scholar
• Challagundla KB, Fanini F, Vannini I, et al. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn. 2014;14(5):565–574. doi:10.1586/14737159.2014.92287924844135
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–579. doi:10.1038/nri85512154376
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/ncb159617486113
   PubMed Web of Science ®Google Scholar
• Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20(5):847–856. doi:10.1038/sj.leu.240413216453000
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39(1):133–144. doi:10.1016/j.molcel.2010.06.01020603081
   PubMed Web of Science ®Google Scholar
• Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci. 2013;14(7):14240–14269. doi:10.3390/ijms14071424023839094
   PubMed Web of Science ®Google Scholar
• Shao Y, Shen Y, Chen T, Xu F, Chen X, Zheng S. The functions and clinical applications of tumor-derived exosomes. Oncotarget. 2016;7(37):60736–60751. doi:10.18632/oncotarget.1117727517627
   PubMedGoogle Scholar
• Grange C, Tapparo M, Collino F, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011;71(15):5346–5356. doi:10.1158/0008-5472.CAN-11-024121670082
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–1476. doi:10.1038/ncb180019011622
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016;126(4):1216–1223. doi:10.1172/JCI8113626927673
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Kumar MS, Pester RE, Chen CY, et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 2009;23(23):2700–2704. doi:10.1101/gad.184820919903759
   PubMed Web of Science ®Google Scholar
• Merritt WM, Bar-Eli M, Sood AK. The dicey role of Dicer: implications for RNAi therapy. Cancer Res. 2010;70:(7)2571–2574. doi:10.1158/0008-5472.CAN-09-253620179193
   PubMed Web of Science ®Google Scholar
• Alemdehy MF, Erkeland SJ. Stop the dicing in hematopoiesis: what have we learned? Cell Cycle. 2012;11(15):2799–2807. doi:10.4161/cc.2107722801545
   PubMed Web of Science ®Google Scholar
• Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A. 2008;105(39):14879–14884. doi:10.1073/pnas.080323010518812516
   PubMed Web of Science ®Google Scholar
• Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15(4):356–362. doi:10.1038/ng0497-3569090379
   PubMed Web of Science ®Google Scholar
• Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–1947.9072974
   PubMed Web of Science ®Google Scholar
• Pulido R. PTEN: a yin-yang master regulator protein in health and disease. Methods. 2015;77-78:3–10. doi:10.1016/j.ymeth.2015.02.00925843297
   PubMed Web of Science ®Google Scholar
• Schabbauer G, Matt U, Gunzl P, et al. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. J Immunol. 2010;185(1):468–476. doi:10.4049/jimmunol.090222120505137
   PubMed Web of Science ®Google Scholar
• Gunzl P, Bauer K, Hainzl E, et al. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J Leukoc Biol. 2010;88(6):1259–1269. doi:10.1189/jlb.011000120884649
   PubMed Web of Science ®Google Scholar
• Sahin E, Haubenwallner S, Kuttke M, et al. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J Immunol. 2014;193(4):1717–1727. doi:10.4049/jimmunol.130216725015834
   PubMed Web of Science ®Google Scholar
• Munder M, Schneider H, Luckner C, et al. Suppression of T-cell functions by human granulocyte arginase. Blood. 2006;108(5):1627–1634. doi:10.1182/blood-2006-11-01038916709924
   PubMed Web of Science ®Google Scholar
• Ibanez-Vea M, Zuazo M, Gato M, et al. Myeloid-derived suppressor cells in the tumor microenvironment: current knowledge and future perspectives. Arch Immunol Ther Exp (Warsz). 2018;66(2):113-123. doi:10.1007/s00005-017-0492-4
   Web of Science ®Google Scholar
• Rodriguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev. 2008;222:180–191. doi:10.1111/j.1600-065X.2008.00608.x18364002
   PubMed Web of Science ®Google Scholar
• Chen W, Jiang J, Xia W, Huang J. Tumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspective. J Immunol Res. 2017;2017:1073947. doi:10.1155/2017/107394728642882
   PubMed Web of Science ®Google Scholar